Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 12;8(1):126-128.
doi: 10.1080/21556660.2019.1619570. eCollection 2019.

Epidemiology of atopic dermatitis in Europe

Affiliations
Review

Epidemiology of atopic dermatitis in Europe

Elżbieta Kowalska-Olędzka et al. J Drug Assess. .

Abstract

Atopic dermatitis (AD) is a chronic inflammatory disease persisting predominantly in the pediatric population. Its development is most presumably multifactorial and a derivative of interplay between genetic, immunologic, and environmental causes. To the authors' knowledge, no multinational and systematic database of AD prevalence is established and maintained for Europe. Thus, epidemiologic data originating from the multinational studies was compiled to draw a picture of AD in both pediatric and adult populations in Europe. The outcomes of this exercise support the general observation that AD prevalence follows the latitudinal pattern with higher prevalence values in northern Europe and decreases progressively towards southern Europe. Noteworthy, the data shows significant differences on the country-level, with higher prevalence in municipal areas than rural. Finally, and unsurprisingly, the collected data reinforces the observation of AD prevalence being highest in pediatric populations in contrast to adults. Herein, data presented was additionally supplemented with the information on current standing on AD etiology.

Keywords: Dermatitis; atopic; epidemiologic studies; humans.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Epidemiology of AD for the 13–14 years age group (Denmark: 12–16 years) and adults according to outcomes from multinational epidemiological research programs8–10 complemented with input for Hungary, Serbia, and the Ukraine from KCR local resources (data marked as “local”). Each country has in brackets a reference of data cited for the 13–14 years age group (left) and adults (right).

Similar articles

Cited by

References

    1. Eichenfield LF, Ahluwalia J, Waldman A, et al. . Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the joint task force practice parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017;139:S49–S57. - PubMed
    1. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol. 1999;140:268–272. - PubMed
    1. Rutkowski K, Sowa P, Rutkowska-Talipska J, et al. . Allergic diseases: the price of civilisational progress. Postepy Dermatol Alergol. 2014;31:77–83. - PMC - PubMed
    1. Gittler JK, Shemer A, Suárez-Fariñas M, et al. . Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130:1344–1354. - PMC - PubMed
    1. Williams H, Stewart A, von Mutius E, International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups, et al. . Is eczema really on the increase worldwide?. J Allergy Clin Immunol. 2008;121:947–954.e15. - PubMed

LinkOut - more resources